中文｜English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Volume 37 Issue 8
Aug.  2021
Turn off MathJax
Article Contents
Article Navigation >  Journal of Clinical Hepatology  > 2021  >  37(8): 1905-1906

Type 1 diabetes mellitus due to pegylated interferon treatment of chronic hepatitis B: A case report

DOI: 10.3969/j.issn.1001-5256.2021.08.031
  • 1.

    Department of Endocrinology, The Fifth Medical Center of Chinese PLA General Hospital, Beijing 100039, China

  • 2.

    Department of Internal Medicine, Hospital of Army 95968 of PLA, Beijing 100195, China

Research funding:

The Innovation Fund Youth Cultivation Project (QNPY2015008)

  • Received Date: 2020-11-29
  • Accepted Date: 2021-01-19
  • Published Date: 2021-08-20
    Abstract
    • FullText(HTML)
  • loading
    • References(6)
  • [1]
    FABRIS P, BETTERLE C, FLOREANI A, et al. Development of type 1 diabetes mellitus during interferon alfa therapy for chronic HCV hepatitis[J]. Lancet, 1992, 340: 548. DOI: 10.1016/0140-6736(92)91744-s.
    [2]
    NEGRO F. Adverse effects of drugs in the treatment of viral hepatitis[J]. Best Pract Res Clin Gastroenterol, 2010, 24(2): 183-192. DOI: 10.1016/j.bpg.2009.10.012.
    [3]
    ZORNITZKI T, MALNICK S, LYSYY L, et al. Interferon therapy in hepatitis C leading to chronic type 1 diabetes[J]. World J Gastroenterol, 2015, 21(1): 233-239. DOI: 10.3748/wjg.v21.i1.233.
    [4]
    WAGURI M, HANAFUSA T, ITOH N, et al. Occurrence of IDDM during interferon therapy for chronic viral hepatitis[J]. Diabetes Res Clin Pract, 1994, 23(1): 33-26. DOI: 10.1016/0168-8227(94)90124-4.
    [5]
    SUKRAN K, GOZAYDIN A, AKKOCLU G, et al. Chronic hepatitis B with type I diabetes mellitus and autoimmune thyroiditis development during interferon alpha therapy[J]. Infect Dev Ctries, 2012, 6(4): 364-368. DOI: 10.3855/jidc.1632.
    [6]
    LV Y, SHI BY, GUO H. Abrupt onset of type 1 diabetes mellitus during recombinant interferon-alpha 2b therapy in a patient with chronic hepatitis B[J]. World J Gastroenterol, 2008, 14(29): 4713-4715. DOI: 10.3748/wjg.14.4713.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Tables(1)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (349) PDF downloads(51) Cited by()
    Proportional views
    Related
        

    The first journal specializing in hepatobiliary and pancreatic diseases in China

    Supervisor：Ministry of Education of the People's Republic of China

    Sponsor：Jilin University

    Academic Support: Chinese Society of Hepatology，Chinese Medical Association

    Address: 461 Xinjiang Road, Changchun

    Submit：0431-88782044

    Peer review：0431-88783542

    Email：lcgdb@vip.163.com

    About Journal

    Submission Guideline

    Journal Online

    Hepatobiliary College

    Guidelines

    YesterdayIP[]YesterdayPV[]TodayIP[]TodayPV[]Online[]

    Website Design © 2020 Editorial Board of Journal of Clinical Hepatology 吉ICP备10000617号-1 Supported by: Beijing Renhe Information Technology Co. Ltd  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return